Dysregulation of GDI2 has been reported in many different cancers, including pancreatic carcinoma [15], ovarian cancer [16,17], gastric cancer [18], thyroid carcinoma [19], hematopoiesis and leukemogenesis [20] and esophageal squamous cell carcinoma [21]. This evidence concerns the gene GDI2 and cancer.